SEC Form 4 · accession 0000899243-17-023126
Deciphera Pharmaceuticals, Inc. · DCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brightstar Associates LLC
10% Owner
Period of report
Oct 2, 2017
Accepted (ET)
Oct 2, 2017 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001654151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 2, 2017 | C | 16,572,370 | — | A | 16,572,370 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF1 | — | Oct 2, 2017 | C | 1,976,134 | D | — | — | Common Stock | 11,165,157 | 0 | D |
| Series B Preferred StockF1 | — | Oct 2, 2017 | C | 297,030 | D | — | — | Common Stock | 1,678,219 | 0 | D |
| Series B-1 Preferred StockF1 | — | Oct 2, 2017 | C | 396,008 | D | — | — | Common Stock | 2,237,445 | 0 | D |
| Series C Preferred StockF1 | — | Oct 2, 2017 | C | 263,991 | D | — | — | Common Stock | 1,491,549 | 0 | D |
Explanation of responses
- F1Represents preferred stock of Deciphera Pharmaceuticals, LLC. Upon the closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into 5.65 shares of common stock of the Issuer.